Missing/wrong data?
Log in to edit
Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial
scientific article published on 22 October 2018
Author/s
author: Vanna Chiarion Sileni, Piotr Rutkowski, Pier Francesco Ferrucci, Ivan Marquez-Rodas, Jedd D. Wolchok, Reinhard Dummer, Dirk Schadendorf
Work details
Publication date
October 22, 2018
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.